March - 2021

RICHARD SEMELKA, MD. CONSULTING

Our Recent Posts

Archive

Tags

Product Insert information and MR Screening form inclusion. My proposals. April 2021

Product Insert information and MR Screening form inclusion. My proposals. April 2021

Product Insert inclusion: Gadolinium Deposition Disease( GDD) is a presumed immunological disease due to retention of Gadolinium in the body. Sufferers may have any level of renal function, including normal. All GBCAs can result in GDD. Disease is characterized by the following: onset within 1 month of GBCA injection (often within minutes), and symptoms* include, but are not restricted to, the following: brain fog, burning skin pain, skin color changes, sharp bone pain, musc

Chelators for GDD Revisited. March 2021

Chelators for GDD Revisited. March 2021

This is intended as a brief blog, and in the not too distant future I will expand it with including the thermodynamic/stability constant values. This seems to be a topic of continued misunderstanding, even by experts. It is also interesting that radiologists and other physician imagers, who understand that thermodynamic stability (stability constant) is the crucial aspect of creating a GBCA, do not understand that the same factor is true for a chelating (decorporation agent).

Diet and exercise. Supplements and Chelation. Short Report.

Diet and exercise. Supplements and Chelation. Short Report.

This is a brief posting. More extensive blogs have been previously posted. Shortly on GadTTRAC a more lengthy report on diet and exercise will be posted. Previous posts have described the importance of a diet composed of anti-inflammatory foods (turmeric) and food elements that can work together in anti-inflammation (cilantro, oregano, chlorella, spirulina), and natural chelators: pectin fruits (peaches, apricots). Read these prior blogs, and look for the postings on GadTTRA

Setting up a Registry of Centers that chelate with DTPA for patients with GDD. GadTTRAC.

Setting up a Registry of Centers that chelate with DTPA for patients with GDD. GadTTRAC.

Over the last couple of years I have worked with patients, from around the US (and the world), who for various reasons are unable to come to Chapel Hill, NC, for DTPA chelation, to work with clinics local to them to treat them for GDD with DTPA. The new Non-Profit: Gadolinium and other heavy metal Toxicity, Treatment Research and Action Center (GadTTRAC) is looking to set up a registry of treating centers. If you are a treating facility, or a patient who has gone to a local t